LDL-C target achievement after adding evinacumab in 2 patients with autosomal recessive hypercholesterolemia

Key Points

• LDL-C levels improved significantly after adding evinacumab to treatment.
• Patient lipid levels showed significant reduction, highlighting the impact of evinacumab therapy.
• Case assessment focused on autosomal recessive hypercholesterolemia and treatment with evinacumab.
• Results indicate promising cholesterol management for this rare genetic condition.